Login / Signup

Synthesis of 1β-hydroxydeoxycholic acid in H-2 and unlabeled forms.

Martin A HayesIeuan RobertsGunnar GrönbergKexin LvBaorui LinJonas BergareCharles S Elmore
Published in: Journal of labelled compounds & radiopharmaceuticals (2017)
1β-hydroxydeoxycholic acid in unlabeled and stable isotope labeled forms was required for use as a biomarker for Cytochrome P450 3A4/5 activity. A lengthy synthesis was undertaken to deliver the unlabeled compound and in the process, to develop a route to the deuterium labeled compound. The synthesis of the unlabeled compound was completed but in a very low yield. Concurrent with the synthetic approach, a biosynthetic route was pursued and this approach proved to be much more rapid and afforded the compound in both unlabeled and deuterium labeled forms in a 1-step oxidation from deoxycholic acid and [D4 ]deoxycholic acid, respectively.
Keyphrases
  • pet imaging
  • radiation therapy
  • locally advanced